925 related articles for article (PubMed ID: 27671657)
21. Therapeutic Targeting of TAZ and YAP by Dimethyl Fumarate in Systemic Sclerosis Fibrosis.
Toyama T; Looney AP; Baker BM; Stawski L; Haines P; Simms R; Szymaniak AD; Varelas X; Trojanowska M
J Invest Dermatol; 2018 Jan; 138(1):78-88. PubMed ID: 28870693
[TBL] [Abstract][Full Text] [Related]
22. Biomimetic nanodrug targets inflammation and suppresses YAP/TAZ to ameliorate atherosclerosis.
Huang HC; Wang TY; Rousseau J; Orlando M; Mungaray M; Michaud C; Plaisier C; Chen ZB; Wang KC
Biomaterials; 2024 Apr; 306():122505. PubMed ID: 38359507
[TBL] [Abstract][Full Text] [Related]
23. Ligation of HLA Class I Molecules Induces YAP Activation through Src in Human Endothelial Cells.
Anwar T; Sinnett-Smith J; Jin YP; Reed EF; Rozengurt E
J Immunol; 2020 Oct; 205(7):1953-1961. PubMed ID: 32848033
[TBL] [Abstract][Full Text] [Related]
24. YAP and TAZ are distinct effectors of corneal myofibroblast transformation.
Muppala S; Raghunathan VK; Jalilian I; Thomasy S; Murphy CJ
Exp Eye Res; 2019 Mar; 180():102-109. PubMed ID: 30578787
[TBL] [Abstract][Full Text] [Related]
25. Hippo pathway-independent restriction of TAZ and YAP by angiomotin.
Chan SW; Lim CJ; Chong YF; Pobbati AV; Huang C; Hong W
J Biol Chem; 2011 Mar; 286(9):7018-26. PubMed ID: 21224387
[TBL] [Abstract][Full Text] [Related]
26. Thromboxane A2 Activates YAP/TAZ Protein to Induce Vascular Smooth Muscle Cell Proliferation and Migration.
Feng X; Liu P; Zhou X; Li MT; Li FL; Wang Z; Meng Z; Sun YP; Yu Y; Xiong Y; Yuan HX; Guan KL
J Biol Chem; 2016 Sep; 291(36):18947-58. PubMed ID: 27382053
[TBL] [Abstract][Full Text] [Related]
27. Synergistic induction of CTGF by cytochalasin D and TGFβ-1 in primary human renal epithelial cells: Role of transcriptional regulators MKL1, YAP/TAZ and Smad2/3.
Muehlich S; Rehm M; Ebenau A; Goppelt-Struebe M
Cell Signal; 2017 Jan; 29():31-40. PubMed ID: 27721022
[TBL] [Abstract][Full Text] [Related]
28. The receptor tyrosine kinase EphA2 promotes glutamine metabolism in tumors by activating the transcriptional coactivators YAP and TAZ.
Edwards DN; Ngwa VM; Wang S; Shiuan E; Brantley-Sieders DM; Kim LC; Reynolds AB; Chen J
Sci Signal; 2017 Dec; 10(508):. PubMed ID: 29208682
[TBL] [Abstract][Full Text] [Related]
29. The Hippo transducers TAZ/YAP and their target CTGF in male breast cancer.
Di Benedetto A; Mottolese M; Sperati F; Ercolani C; Di Lauro L; Pizzuti L; Vici P; Terrenato I; Sperduti I; Shaaban AM; Sundara-Rajan S; Barba M; Speirs V; De Maria R; Maugeri-Saccà M
Oncotarget; 2016 Jul; 7(28):43188-43198. PubMed ID: 27248471
[TBL] [Abstract][Full Text] [Related]
30. The PDZ-binding motif of Yes-associated protein is required for its co-activation of TEAD-mediated CTGF transcription and oncogenic cell transforming activity.
Shimomura T; Miyamura N; Hata S; Miura R; Hirayama J; Nishina H
Biochem Biophys Res Commun; 2014 Jan; 443(3):917-23. PubMed ID: 24380865
[TBL] [Abstract][Full Text] [Related]
31. Proliferation of hepatic stellate cells, mediated by YAP and TAZ, contributes to liver repair and regeneration after liver ischemia-reperfusion injury.
Konishi T; Schuster RM; Lentsch AB
Am J Physiol Gastrointest Liver Physiol; 2018 Apr; 314(4):G471-G482. PubMed ID: 29351389
[TBL] [Abstract][Full Text] [Related]
32. Sensitisation of Cancer Cells to MLN8237, an Aurora-A Inhibitor, by YAP/TAZ Inactivation.
Oku Y; Nishiya N; Sugiyama S; Sato H; Uehara Y
Anticancer Res; 2018 Jun; 38(6):3471-3476. PubMed ID: 29848699
[TBL] [Abstract][Full Text] [Related]
33. Shear-Induced CCN1 Promotes Atheroprone Endothelial Phenotypes and Atherosclerosis.
Hsu PL; Chen JS; Wang CY; Wu HL; Mo FE
Circulation; 2019 Jun; 139(25):2877-2891. PubMed ID: 30917686
[TBL] [Abstract][Full Text] [Related]
34. TIAM1 Antagonizes TAZ/YAP Both in the Destruction Complex in the Cytoplasm and in the Nucleus to Inhibit Invasion of Intestinal Epithelial Cells.
Diamantopoulou Z; White G; Fadlullah MZH; Dreger M; Pickering K; Maltas J; Ashton G; MacLeod R; Baillie GS; Kouskoff V; Lacaud G; Murray GI; Sansom OJ; Hurlstone AFL; Malliri A
Cancer Cell; 2017 May; 31(5):621-634.e6. PubMed ID: 28416184
[TBL] [Abstract][Full Text] [Related]
35. Low-Intensity Pulsed Ultrasound Treatment Accelerates Angiogenesis by Activating YAP/TAZ in Human Umbilical Vein Endothelial Cells.
Xu XM; Xu TM; Wei YB; Gao XX; Sun JC; Wang Y; Kong QJ; Shi JG
Ultrasound Med Biol; 2018 Dec; 44(12):2655-2661. PubMed ID: 30205992
[TBL] [Abstract][Full Text] [Related]
36. Central role of Yes-associated protein and WW-domain-containing transcriptional co-activator with PDZ-binding motif in pancreatic cancer development.
Rozengurt E; Eibl G
World J Gastroenterol; 2019 Apr; 25(15):1797-1816. PubMed ID: 31057295
[TBL] [Abstract][Full Text] [Related]
37. Deletion of BACH1 Attenuates Atherosclerosis by Reducing Endothelial Inflammation.
Jia M; Li Q; Guo J; Shi W; Zhu L; Huang Y; Li Y; Wang L; Ma S; Zhuang T; Wang X; Pan Q; Wei X; Qin Y; Li X; Jin J; Zhi X; Tang J; Jing Q; Li S; Jiang L; Qu L; Osto E; Zhang J; Wang X; Yu B; Meng D
Circ Res; 2022 Apr; 130(7):1038-1055. PubMed ID: 35196865
[TBL] [Abstract][Full Text] [Related]
38. Integrin signalling regulates YAP and TAZ to control skin homeostasis.
Elbediwy A; Vincent-Mistiaen ZI; Spencer-Dene B; Stone RK; Boeing S; Wculek SK; Cordero J; Tan EH; Ridgway R; Brunton VG; Sahai E; Gerhardt H; Behrens A; Malanchi I; Sansom OJ; Thompson BJ
Development; 2016 May; 143(10):1674-87. PubMed ID: 26989177
[TBL] [Abstract][Full Text] [Related]
39. YAP and the RhoC regulator ARHGAP18, are required to mediate flow-dependent endothelial cell alignment.
Coleman PR; Lay AJ; Ting KK; Zhao Y; Li J; Jarrah S; Vadas MA; Gamble JR
Cell Commun Signal; 2020 Feb; 18(1):18. PubMed ID: 32013974
[TBL] [Abstract][Full Text] [Related]
40. The Hippo pathway mediates inhibition of vascular smooth muscle cell proliferation by cAMP.
Kimura TE; Duggirala A; Smith MC; White S; Sala-Newby GB; Newby AC; Bond M
J Mol Cell Cardiol; 2016 Jan; 90():1-10. PubMed ID: 26625714
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
